These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37337462)

  • 21. Outcomes After Coronary Stenting or Bypass Surgery for Men and Women With Unprotected Left Main Disease: The EXCEL Trial.
    Serruys PW; Cavalcante R; Collet C; Kappetein AP; Sabik JF; Banning AP; Taggart DP; Sabaté M; Pomar J; Boonstra PW; Lembo NJ; Onuma Y; Simonton CA; Morice MC; McAndrew T; Dressler O; Stone GW
    JACC Cardiovasc Interv; 2018 Jul; 11(13):1234-1243. PubMed ID: 29976359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ischemic and bleeding risk after complex percutaneous coronary intervention in patients with or without high bleeding risk.
    Yamamoto K; Shiomi H; Morimoto T; Takeji Y; Yoshikawa Y; Natsuaki M; Watanabe H; Tada T; Tazaki J; Yamaji K; Tamura T; Ando K; Kadota K; Furukawa Y; Nakagawa Y; Kimura T
    Catheter Cardiovasc Interv; 2021 May; 97(6):E758-E770. PubMed ID: 33064372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of patients at higher risk for myocardial injury following elective coronary artery intervention.
    Abu Sharar H; Helfert S; Vafaie M; Pleger ST; Chorianopoulos E; Bekeredjian R; Katus HA; Giannitsis E
    Catheter Cardiovasc Interv; 2020 Sep; 96(3):578-585. PubMed ID: 31638330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic and Practical Validation of Current Definitions of Myocardial Infarction Associated With Percutaneous Coronary Intervention.
    Tricoci P; Newby LK; Clare RM; Leonardi S; Gibson CM; Giugliano RP; Armstrong PW; Van de Werf F; Montalescot G; Moliterno DJ; Held C; Aylward PE; Wallentin L; Harrington RA; Braunwald E; Mahaffey KW; White HD
    JACC Cardiovasc Interv; 2018 May; 11(9):856-864. PubMed ID: 29747915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet reactivity and cardiovascular events after percutaneous coronary intervention in patients with stable coronary artery disease: the Stent Thrombosis In Belgium (STIB) trial.
    Legrand V; Cuisset T; Chenu P; Vrolix M; Martinez C; Dens J; Gach O; Boland J; Claeys MJ; Magne J; Barbato E; Wijns W
    EuroIntervention; 2014 Jun; 10(2):204-11. PubMed ID: 24952058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical outcomes according to lesion complexity in high bleeding risk patients treated with 1-month dual antiplatelet therapy following PCI: Analysis from the Onyx ONE clear study.
    Kandzari DE; Kirtane AJ; Mehran R; Price MJ; Simon DI; Latib A; Kedhi E; Abizaid A; Worthley SG; Zaman A; Hudec M; Stoler R; Choi JW; Kanitkar M; Conradie A; Tam CF; Walton A; Gruberg L; Ando K; Lee LC; Lung TH; Windecker S; Stone GW
    Catheter Cardiovasc Interv; 2022 Feb; 99(3):583-592. PubMed ID: 34478233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Type 4a myocardial infarction: Incidence, risk factors, and long-term outcomes.
    Yang X; Tamez H; Lai C; Ho K; Cutlip D
    Catheter Cardiovasc Interv; 2017 Apr; 89(5):849-856. PubMed ID: 27535209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of periprocedural versus spontaneously occurring myocardial infarction after percutaneous coronary intervention in patients with acute coronary syndromes: an analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial.
    Prasad A; Gersh BJ; Bertrand ME; Lincoff AM; Moses JW; Ohman EM; White HD; Pocock SJ; McLaurin BT; Cox DA; Lansky AJ; Mehran R; Stone GW
    J Am Coll Cardiol; 2009 Jul; 54(5):477-86. PubMed ID: 19628125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Percutaneous Coronary Intervention Complexity and Risk of Adverse Events in relation to High Bleeding Risk among Patients Receiving Drug-Eluting Stents: Insights from a Large Single-Center Cohort Study.
    Wang HY; Wang Y; Yin D; Gao RL; Yang YJ; Xu B; Dou KF
    J Interv Cardiol; 2020; 2020():2985435. PubMed ID: 32405273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes After Left Main Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting According to Lesion Site: Results From the EXCEL Trial.
    Gershlick AH; Kandzari DE; Banning A; Taggart DP; Morice MC; Lembo NJ; Brown WM; Banning AP; Merkely B; Horkay F; van Boven AJ; Boonstra PW; Dressler O; Sabik JF; Serruys PW; Kappetein AP; Stone GW
    JACC Cardiovasc Interv; 2018 Jul; 11(13):1224-1233. PubMed ID: 29976358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparison on the long-term outcomes post percutaneous coronary intervention or coronary artery bypass grafting for bifurcation lesions in unprotected left main coronary artery].
    Yang BG; Yu XP; Chen F; Lyu SZ; Li Q; He JQ; Yuan F
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):19-25. PubMed ID: 28100341
    [No Abstract]   [Full Text] [Related]  

  • 32. Vitamin D deficiency and periprocedural myocardial infarction in patients undergoing percutaneous coronary interventions.
    Verdoia M; Ceccon C; Nardin M; Suryapranata H; De Luca G;
    Cardiovasc Revasc Med; 2018 Oct; 19(7 Pt A):744-750. PubMed ID: 29656938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of the Polymorphism rs5751876 of the Purinergic Receptor ADORA2A on Periprocedural Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention.
    Negro F; Verdoia M; Nardin M; Suryapranata H; Kedhi E; Dudek D; De Luca G;
    J Atheroscler Thromb; 2021 Feb; 28(2):137-145. PubMed ID: 33342966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinical approach to diagnosing peri-procedural myocardial infarction after percutaneous coronary interventions according to the fourth universal definition of myocardial infarction - from the study group on biomarkers of the European Society of Cardiology (ESC) Association for Acute CardioVascular Care (ACVC).
    Mair J; Jaffe A; Lindahl B; Mills N; Möckel M; Cullen L; Giannitsis E; Hammarsten O; Huber K; Krychtiuk K; Mueller C; Thygesen K
    Biomarkers; 2022 Jul; 27(5):407-417. PubMed ID: 35603440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loading doses of ticagrelor versus clopidogrel in preventing periprocedural myocardial infarction in Asian patients with acute coronary syndrome.
    Zhang YR; Xue ZK; Chen KY; Xu LX; Wang WD; Tao HY; Liu T; Che JJ; Wang XW; Rha SW; Wang JR; Wang P
    Perfusion; 2021 Mar; 36(2):122-129. PubMed ID: 32522095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of diabetes mellitus on periprocedural myocardial infarction in patients undergoing coronary stent implantation.
    Verdoia M; Barbieri L; Schaffer A; Cassetti E; Di Giovine G; Nardin M; Bellomo G; Marino P; De Luca G;
    Diabetes Metab Res Rev; 2015 Jan; 31(1):85-92. PubMed ID: 24898423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rosuvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of myocardial periprocedural necrosis: the ROMA trial.
    Sardella G; Conti G; Donahue M; Mancone M; Canali E; De Carlo C; Di Roma A; Calcagno S; Lucisano L; Fedele F
    Catheter Cardiovasc Interv; 2013 Jan; 81(1):E36-43. PubMed ID: 22517610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complex vs. non-complex percutaneous coronary intervention with newer-generation drug-eluting stents: an analysis from the randomized BIOFLOW trials.
    Hemetsberger R; Abdelghani M; Toelg R; Garcia-Garcia HM; Farhan S; Mankerious N; Elbasha K; Allali A; Windecker S; Lefèvre T; Saito S; Kandzari D; Waksman R; Richardt G
    Clin Res Cardiol; 2022 Jul; 111(7):795-805. PubMed ID: 35212802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta-Analysis of Bare Metal Stent and Drug-Eluting Stent Trials.
    Alsidawi S; Effat M; Rahman S; Abdallah M; Leesar M
    Cardiovasc Ther; 2015 Dec; 33(6):360-6. PubMed ID: 26363283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.